Surpasses over 1000 colorectal robotic surgeries, maximum till date in the country Readmission rates of less than 1.9% compared to global standard of 21.4% reflects the quality of surgery and care delivered at Apollo Apollo’s advanced robotic colorectal cancer surgeries see, 40% patients coming from
Shalby Limited, India’s leading multi-specialty hospital, has announced its financial results for the quarter ending on December 31, 2022. Consolidated Performance Highlights: Q3 FY2023 vs Q3 FY2022 Consolidated Revenues of Rs. 2,067 million, growth of 25.1% y-o-y Consolidated EBITDA of Rs. 380 million, growth of 22.5%
